Go to content
UR Home

Long-term management of multiple sclerosis patients treated with cladribine tablets: an expert opinion

Meuth, Sven G. ; Bayas, Antonios ; Kallmann, Boris ; Kleinschnitz, Christoph ; Linker, Ralf ; Rieckmann, Peter ; Mäurer, Mathias


Introduction Oral cladribine is a highly effective pulsed selective immune reconstitution therapy licensed for relapsing multiple sclerosis. A full treatment course comprises two treatment cycles given with 1 year of intermission. Further dosing is not routinely recommended in years 3 and 4. Areas covered The long-term management of patients treated with oral cladribine has not been fully defined ...


Owner only: item control page
  1. Homepage UR

University Library

Publication Server


Publishing: oa@ur.de
0941 943 -4239 or -69394

Dissertations: dissertationen@ur.de
0941 943 -3904

Research data: datahub@ur.de
0941 943 -5707

Contact persons